Capstone Investment Advisors
DXCM icon

Capstone Investment Advisors’s DexCom DXCM Stock Holding History

Capstone Investment Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.22M Buy
83,200
+2,400
+3% +$167K 0.01% 410
2025
Q4 		$5.36M Sell
80,800
-167,100
-67% -$10.8M 0.01% 353
2025
Q3 		$16.7M Buy
247,900
+205,900
+490% +$16.3M 0.03% 231
2025
Q2 		$3.67M Sell
42,000
-24,300
-37% -$1.9M 0.01% 463
2025
Q1 		$4.53M Sell
66,300
-14,100
-18% -$1.15M 0.01% 483
2024
Q4 		$6.25M Buy
80,400
+11,100
+16% +$822K 0.02% 469
2024
Q3 		$4.65M Sell
69,300
-30,000
-30% -$2.46M 0.01% 480
2024
Q2 		$11.3M Buy
99,300
+43,100
+77% +$5.45M 0.04% 290
2024
Q1 		$7.79M Sell
56,200
-15,300
-21% -$1.92M 0.03% 321
2023
Q4 		$8.87M Buy
71,500
+49,900
+231% +$5.1M 0.03% 371
2023
Q3 		$2.02M Buy
21,600
+1,900
+10% +$214K 0.01% 723
2023
Q2 		$2.53M Buy
19,700
+1,700
+9% +$206K 0.01% 569
2023
Q1 		$2.09M Sell
18,000
-31,600
-64% -$3.54M 0.01% 585
2022
Q4 		$5.62M Buy
49,600
+2,000
+4% +$220K 0.04% 355
2022
Q3 		$3.83M Buy
47,600
+4,800
+11% +$407K 0.02% 486
2022
Q2 		$3.19M Sell
42,800
-82,000
-66% -$7.48M 0.02% 565
2022
Q1 		$16M Sell
124,800
-154,800
-55% -$16.9M 0.04% 314
2021
Q4 		$37.5M Buy
279,600
+1,200
+0.4% +$172K 0.06% 275
2021
Q3 		$38.1M Sell
278,400
-21,200
-7% -$2.67M 0.08% 243
2021
Q2 		$32M Buy
299,600
+54,400
+22% +$5.22M 0.07% 247
2021
Q1 		$22M Buy
245,200
+120,000
+96% +$11.3M 0.06% 279
2020
Q4 		$11.6M Buy
125,200
+42,400
+51% +$3.79M 0.04% 361
2020
Q3 		$8.53M Buy
82,800
+400
+0.5% +$41.8K 0.04% 362
2020
Q2 		$8.35M Buy
+82,400
New +$7.37M 0.06% 299

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capstone Investment Advisors's DXCM Position: Q1 2026 in Review

Capstone Investment Advisors increased its DexCom (DXCM) stake by 5.5% in Q1 2026, buying an estimated $198K and bringing the position to 54,715 shares worth $3.44M. The position accounts for 0.01% of the portfolio, ranked #504.

Capstone Investment Advisors first reported a position in DXCM in Q4 2020 and has held it in 16 quarters since. The position peaked at $8.04M in Q3 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Capstone Investment Advisors held 54,715 shares of DexCom worth $3.44M as of Q1 2026.
  • Capstone Investment Advisors bought 2,840 DexCom shares in Q1 2026, an estimated $198K.
  • DexCom made up 0.01% of Capstone Investment Advisors's portfolio in Q1 2026, its #504 holding.
  • Capstone Investment Advisors first reported a position in DexCom in Q4 2020 and has held it in 16 quarters since.
  • Capstone Investment Advisors's DexCom position peaked at $8.04M in Q3 2025.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.